Skip to main content

Table 4 Proportion of clinical characteristics

From: Partner HIV serostatus disclosure and determinants of serodiscordance among prevention of mother to child transmission clients in Nigeria

Variables

Total

Seroconcordant

Serodiscordant

Chi-square (p-value)

Symetric measures

n

%

n

%

n

%

 

Cramer’s V

Phi coefficient

Baseline CD4+ count

      

0.143 (0.706)

 

0.04

CD4 < 350

40

100

22

55.0

18

45.0

   

CD4 > 350

76

100

39

51.3

37

48.7

   

WHO clinical staging

      

8.751 (0.003)*

 

−0.15

Asymptomatic

373

100

178

47.7

195

52.3

   

Symptomatic

15

100

13

86.7

2

13.3

   
  1. *Significant (P-value < 0.05)